Patents by Inventor Norifumi Tateishi

Norifumi Tateishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10342773
    Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: July 9, 2019
    Assignee: SUNTORY HOLDINGS LIMITED
    Inventors: Norifumi Tateishi, Hiroshi Kawashima
  • Publication number: 20180193298
    Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.
    Type: Application
    Filed: March 5, 2018
    Publication date: July 12, 2018
    Applicant: SUNTORY HOLDINGS LIMITED
    Inventors: Norifumi TATEISHI, Hiroshi KAWASHIMA
  • Patent number: 9943495
    Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: April 17, 2018
    Assignee: SUNTORY HOLDINGS LIMITED
    Inventors: Norifumi Tateishi, Hiroshi Kawashima
  • Publication number: 20180071248
    Abstract: The purporse of the present invention is to provide a circadian rhythm improving composition which can be safely taken over a long time, in particular, a circadian rhythm controlling composition capable of increasing circadian rhythm amplitude. Provided is a circadian rhythm improving composition comprising one or more kindes of lignan compounds.
    Type: Application
    Filed: March 22, 2016
    Publication date: March 15, 2018
    Applicant: SUNTORY HOLDINGS LIMITED
    Inventors: Norifumi TATEISHI, Shigenobu SHIBATA
  • Patent number: 9895375
    Abstract: The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound(s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are synergistically improved by ingestion of riboflavin in combination with a sesamin-class compound(s). The composition of the present invention provides compositions, in particular, pharmaceuticals as well as foods and beverages that are safe to humans, animals, etc., and can therefore be ingested for a continued period, and which have far superior effects to those of conventional foods having an analgesic or anti-fatigue action.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: February 20, 2018
    Assignee: SUNTORY HOLDINGS LIMITED
    Inventors: Daisuke Takemoto, Norifumi Tateishi, Yoshiko Ono, Kayo Saito, Akifumi Maeda
  • Patent number: 9609884
    Abstract: Anti-fatigue agents containing dioxabicyclo[3.3.0]octane derivatives such as sesamin which is an ingredient contained in sesame, as well as pharmaceutical compositions and physiologically functional foods that contain such anti-fatigue agents are disclosed. These compounds can safely be administered to humans and animals alike and hence allow for continued ingestion while proving effective in promoting an improvement of stamina, an increase of body strength, a relief of fatigue, and recovery from fatigue.
    Type: Grant
    Filed: March 12, 2008
    Date of Patent: April 4, 2017
    Assignee: Suntory Holdings Limited
    Inventors: Yoshiko Ono, Kayo Saito, Norifumi Tateishi, Akifumi Maeda
  • Publication number: 20150182486
    Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.
    Type: Application
    Filed: March 11, 2015
    Publication date: July 2, 2015
    Applicant: SUNTORY HOLDINGS LIMITED
    Inventors: Norifumi TATEISHI, Hiroshi KAWASHIMA
  • Patent number: 9006287
    Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: April 14, 2015
    Assignee: Suntory Holdings Limited
    Inventors: Norifumi Tateishi, Hiroshi Kawashima
  • Publication number: 20150080407
    Abstract: The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound (s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are synergistically improved by ingestion of riboflavin in combination with a sesamin-class compound(s). The composition of the present invention provides compositions, in particular, pharmaceuticals as well as foods and beverages that are safe to humans, animals, etc. and can therefore be ingested for a continued period, and which have far superior effects to those of conventional foods having an analgesic or anti-fatigue action.
    Type: Application
    Filed: November 24, 2014
    Publication date: March 19, 2015
    Applicant: SUNTORY HOLDINGS LIMITED
    Inventors: Daisuke TAKEMOTO, Norifumi TATEISHI, Yoshiko ONO, Kayo SAITO, Akifumi MAEDA
  • Patent number: 8507547
    Abstract: Disclosed is a composition which is safe for a human body and an animal, can be ingested continuously on a daily basis, has an anti-fatigue activity, and is effective for the prevention or treatment of a disease or condition associated with fatigue. Specifically disclosed is an anti-fatigue agent comprising andrographolide optionally together with an ?-lipoic acid as an active ingredient(s). Also disclosed is a novel oral composition comprising andrographolide and an ?-lipoic acid. The anti-fatigue agent and the oral composition are useful for the prevention or treatment of chronic fatigue syndrome, overfatigue, physical fatigue, mental fatigue and organ fatigue.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: August 13, 2013
    Assignee: Suntory Holdings Limited
    Inventors: Sumio Asami, Kayo Saito, Akifumi Maeda, Norifumi Tateishi
  • Publication number: 20100144866
    Abstract: Disclosed is a composition which is safe for a human body and an animal, can be ingested continuously on a daily basis, has an anti-fatigue activity, and is effective for the prevention or treatment of a disease or condition associated with fatigue. Specifically disclosed is an anti-fatigue agent comprising andrographolide optionally together with an ?-lipoic acid as an active ingredient(s). Also disclosed is a novel oral composition comprising andrographolide and an ?-lipoic acid. The anti-fatigue agent and the oral composition are useful for the prevention or treatment of chronic fatigue syndrome, overfatigue, physical fatigue, mental fatigue and organ fatigue.
    Type: Application
    Filed: May 30, 2008
    Publication date: June 10, 2010
    Applicant: Suntory Holdings Limited
    Inventors: Sumio Asami, Kayo Saito, Akifumi Maeda, Norifumi Tateishi
  • Publication number: 20100048695
    Abstract: Anti-fatigue agents containing dioxabicyclo[3.3.0]octane derivatives such as sesamin which is an ingredient contained in sesame, as well as pharmaceutical compositions and physiologically functional foods that contain such anti-fatigue agents are disclosed. These compounds can safely be administered to humans and animals alike and hence allow for continued ingestion while proving effective in promoting an improvement of stamina, an increase of body strength, a relief of fatigue, and recovery from fatigue.
    Type: Application
    Filed: March 12, 2008
    Publication date: February 25, 2010
    Inventors: Yoshiko Ono, Kayo Saito, Norifumi Tateishi, Akifumi Maeda
  • Publication number: 20090143317
    Abstract: The present invention provides an ?-glycosyl isoquercitrin-containing novel composition which has a high in vivo absorbability, and hence exhibits a significant in vivo antioxidative activity. The present invention further provides preparation methods for such a composition. The composition contains a mixture of quercetin glycosides represented by the following formula: wherein Glc represents a glucose residue, and n is 0 or a positive integer of 1 or more, includes at least a quercetin glycoside wherein n is 3, and satisfies the following requirement (a): (a) the total proportion of quercetin glycosides in which n is 3, and in which other n values may be 1 or 2, or 1 and 2, is 50 mol % or more, and the total proportion of quercetin glycosides wherein n is 4 or more is 15 mol % or less, in the composition. The composition can be prepared by treating an enzymatically modified isoquercitrin with ?-amylase.
    Type: Application
    Filed: December 28, 2005
    Publication date: June 4, 2009
    Applicants: Suntory Limited, SAN-EI GEN F.F.I., INC.
    Inventors: Yoshiko Ono, Namino Tomimori, Norifumi Tateishi, Masamitsu Moriwaki, Kazuhiro Emura, Shuji Okuyama
  • Publication number: 20090054443
    Abstract: The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound(s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are synergistically improved by ingestion of riboflavin in combination with a sesamin-class compound(s). The composition of the present invention provides compositions, in particular, pharmaceuticals as well as foods and beverages that are safe to humans, animals, etc. and can therefore be ingested for a continued period, and which have far superior effects to those of conventional foods having an analgesic or anti-fatigue action.
    Type: Application
    Filed: March 15, 2007
    Publication date: February 26, 2009
    Applicant: SUNTORY LIMITED
    Inventors: Daisuke Takemoto, Norifumi Tateishi, Yoshiko Ono, Kayo Saito, Akifumi Maeda
  • Publication number: 20080108699
    Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.
    Type: Application
    Filed: February 10, 2006
    Publication date: May 8, 2008
    Applicant: SUNTORY LIMITED
    Inventors: Norifumi Tateishi, Hiroshi Kawashima
  • Publication number: 20050163831
    Abstract: A patch for transdermal administration having a sufficiently high transdermal permeation property of a COX-2 inhibitor to exert a superior antiinflammatory effect, the patch for transdermal administration comprising a backing and an adhesive layer which is placed on at least one side of the backing and comprises an adhesive base agent and a drug, wherein the drug is valdecoxib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 1, 2005
    Publication date: July 28, 2005
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Atsutoshi Ikesue, Norifumi Tateishi, Kengo Uemura, Takaaki Terahara, Naruhito Higo, Michinori Sakai